Successful preoperative chemotherapy with S-1 plus low-dose cisplatin for advanced gastric cancer with synchronous liver metastases: Report of 2 cases

Chemotherapy

Volumn 53, Issue 5, 2007, Pages 378-382

  Takahashi, Naoto ^a   Nimura, Hiroshi ^a   Aoki, Hiroaki ^a   Koyama, Tomoki ^a   Mitsumori, Norio ^a   Aiba, Keisuke ^a   Kashiwagi, Hideyuki ^a   Yanaga, Katsuhiko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Concomitant liver metastases; Gastric cancer; Preoperative chemotherapy

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CASE REPORT; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DISEASE COURSE; ENDOSCOPIC BIOPSY; FEVER; HEMATOLOGIC DISEASE; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; LAPAROTOMY; LIVER METASTASIS; LOW DRUG DOSE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RASH; STOMACH CANCER; TREATMENT RESPONSE;

CISPLATIN; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OXONIC ACID; PREOPERATIVE CARE; STOMACH NEOPLASMS; TEGAFUR; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 34548662614     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107726     Document Type: Article

References (22)

1. Maruyama K, Kaminishi N, Katai H, Hayashi K, Honda I, Isobe Y, Arai K, Committee of Nationwide Registry: Japanese Gastric Cancer Association nationwide registry of gastric cancer patients in Japan (in Japanese with English abstract). Gan no Rinsyo 1999;45:719-724.
2. Okano K, Maeba T, Ishimura K, Karasawa Y, Goda F, Wakabayashi H, Usuki H, Maeta H: Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 2002;235:86-91.
3. Fujisaki S, Tomita R, Nezu T, Kimizuka K, Park E, Fukuzawa M: Prognostic studies on gastric cancer with concomitant liver metastases. Hepatogastroenterology 2001;48:892-894.
4. Ajani JA, Mansfield PF, Crane CH, Wu TT, Lunagomez S, Lynch PM, Janjan N, Feig B, Faust J, Yao JC, Nivers R, Morris J, Pisters PW: Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol 2005;23:1237-1244.
5. Ajani JA, Mansfield PF, Lynch PM, Pisters PW, Feig B, Dumas P, Evans DB, Raijman I, Hargraves K, Curley S, Ota DM: Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. J Clin Oncol 1999;17:2403-2411.
6. Nakane Y, Inoue K, Michiura T, Nakai K, Sato M, Baden T, Okumura S, Yamamichi K: Combined S-1 and cisplatin preoperative chemotherapy for patients with advanced gastric cancer: report of five cases. Hepatogastroenterology 2004;51:289-293.
7. Yoshida I, Sakurai Y, Komori Y, Tonomura S, Masui T, Shoji M, Nakamura Y, Imazu H, Uyama I, Ochiai M: Successful downstaging by S-1-based chemotherapy followed by surgical resections for gastric carcinoma with extensive distant lymph node metastasis - report of two cases and a review of cases with surgical resection after downstaging by S-1-based chemotherapy. Hepatogastroenterology 2005;52:978-984.
8. Chollet P, Schoffski P, Weigang-Kohler K, Schellens JH, Cure H, Pavlidis N, Grunwald V, De Boer R, Wanders J, Fumoleau P, EORTC Early Clinical Studies Group: Phase II trial with S-1 in chemotherapy-naive patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG). Eur J Cancer 2003;39:1264-1270.
9. Sakata Y, Ohtsu A, Horikoshi N, Sugimachi K, Mitachi Y, Taguchi T: Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4M gimestat-1 M otastat potassium) in advanced gastric cancer patients. Eur J Cancer 1998;34:1715-1720.
10. Koizumi W, Kurihara M, Nakano S, Hasegawa K: Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group. Oncology 2000;58:191-197.
11. Koizumi W, Tanabe S, Saigenji K, Ohtsu A, Boku N, Nagashima F, Shirao K, Matsumura Y, Gotoh M: Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Cancer 2003;89:2207-2212.
12. Japanese Research Society for Gastric Cancer: Japanese Classification of Gastric Carcinoma, ed 2. Tokyo, Kanehara, 1998.
13. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 1981;47:207-214.
14. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1,001 consecutive cases. Ann Surg 1999;230:309-318; discussion 318-321.
15. Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Sakamoto M, Fukuda H: Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg 1999;86:332-337.
16. Ochiai T, Sasako M, Mizuno S, Kinoshita T, Takayama T, Kosuge T, Yamazaki S, Maruyama K: Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg 1994;81:1175-1178.
17. Miyazaki M, Itoh H, Nakagawa K, Ambiru S, Shimizu H, Togawa A, Shiobara M, Ohtsuka M, Sasada K, Shimizu Y, Yoshioka S, Nakajima N, Suwa T, Kimura F: Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol 1997;92:490-493.
18. Maehara Y, Moriguchi S, Kakeji Y, Kohnoe S, Korenaga D, Haraguchi M, Sugimachi K: Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery 1991;110:820-823.
19. Okuyama K, Isono K, Juan IK, Onoda S, Ochiai T, Yamamoto Y, Koide Y, Satoh H: Evaluation of treatment for gastric cancer with liver metastasis. Cancer 1985;55:2498-2505.
20. Fink U, Stein HJ, Schuhmacher C, Wilke HJ: Neoadjuvant chemotherapy for gastric cancer: update. World J Surg 1995;19:509-516.
21. Hyodo I, Nishina T, Moriwaki T, Endo S, Terao T, Hirao K, Nasu J, Hirasaki S, Endo H, Masumoto T, Tajiri H, Kurita A: A phase I study of S-1 combined with weekly cisplatin for metastatic gastric cancer in an outpatient setting. Eur J Cancer 2003;39:2328-2333.
22. Ajani JA, Lee FC, Singh DA, Haller DG, Lenz HJ, Benson AB 3rd, Yanagihara R, Phan AT, Yao JC, Strumberg D: Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma. J Clin Oncol 2006;24:663-667.